Millie: Search Results

Editor s Note: This article was published in Pharmaceutical Technology Europe s December 2019 print issue. loped in the 1920s, design of experiments (DoE) has become an indispensable tool for drug developers who seek to gain deeper insights into their products and processes.

As the pharmaceutical supply chain becomes more complex, potential vulnerabilities are increasing. Adding to the challenge are random and unpredictable supply disruptions caused by acts of violence, fires, floods, or natural disasters. Survival depends on understanding and collaborating wi.

CURTO - STOCK.ADOBE.COM The proportion of poorly soluble molecules entering the drug development pipeline is increasing year-on-year, raising the bar for pharmaceutical companies in terms of how best to approach the challenge of improving solubility and bioavailability.

Editor s Note: This article was published in Pharmaceutical Technology Europe s December 2019 print issue. Digitalization is spreading rapidly throughout Europe s healthcare and pharmaceutical sectors. But the pace of the change is leaving regulators struggling to keep up. Vast amo.

PIXEL-SHOT - STOCK.ADOBE.COM Extractables and leachables (E&L) testing, to a certain degree, is a requirement for nearly all drug product submissions to the relevant regulatory bodies, unsurprising given the fact that patient safety is of paramount importance.

Editor s Note: This article was published in Pharmaceutical Technology Europe s December 2019 print issue. Not since 1923 has the general public of the United Kingdom been sent to the polling stations in the month of December (1). However, the wish of the current UK prime minister,

AGSANDREW- STOCK.ADOBE.COM Excipients are essential components of drug formulations. While physiologically inert, they have functionalities that achieve many formulation goals, such as API stabilization, taste masking, and extended release. Functional excipients play an integral role i.

A recent survey of pharma industry experts revealed the US pharmaceutical industry continues to lead global peers in innovation and competitiveness; however, the United States trails China, India, and Germany in overall market growth potential. The survey, CPhI Pharma Industry Rankings, which po.

Cambrex Corporation announced on Dec. 4, 2019 that the company s sale to an affiliate of the Permira funds completion has been completed. In August 2019, the company reported an acquisition agreement valued at approximately $2.4 billion. In a Dec. 4, 2019 press statement, Cambrex noted.

FDA has approved three applications for first generics of Novartis Gilenya (fingolimod) capsules for treating relapsing forms of multiple sclerosis (MS) in adult patients, the agency announced on Dec. 5, 2019. FDA granted the generic approvals to HEC Pharm, a private pharmaceutical company in C.

GE Healthcare Life Sciences announced the launch of its SpinOculation C-Pro Protocol Software for cell therapy workflow on Dec. 2, 2019. The new software is part of the Sepax C-Pro Cell Processing System and, when used with the Sepax C-Pro instrument and CT-60.1 single-use kit, lets users.

CSafe Global, a Dayton, OH-based container solutions company focused on transporting pharmaceuticals, announced it is opening a new technical service center at the Memphis International Airport (MEM) in Memphis, TN, on Dec. 5, 2019. According to a company press release, the newly operation.

Stevanato Group, an Italy-based glass primary packaging producer, announced on Dec. 4, 2019 that it has started construction on a new Technology Excellence Center (TEC) in Boston, MA, to further its presence in the United States biopharma drug development landscape. According to a company.

PCI Pharma Services, a pharmaceutical and biopharmaceutical outsourcing solutions provider based in Philadelphia, PA, announced on Dec. 4, 2019 that it completed an expansion at its Rockford, IL, facility to expand its specialty drug product capabilities. The newly expanded facility is the.

Seventyfour - Stock.adobe.com As we witness a health revolution with the development of biological medicines, biopharmaceutical companies are still facing major challenges around how to manufacture these drugs and get them to market as quickly and safely as possible. The wide ran.

Pharmaceutical and biopharmaceutical companies have been extensively using contract research organizations (CROs) to meet their challenging needs in R&D and standard work for several decades. A noticeable shift occurred in outsourcing research and clinical work when Big Pharma R&D costs.

topone/Stock.Adobe.com Two of the world s most complex manufacturing industries semiconductor fabrication and biopharmaceutical production share a common fundamental objective: to maximize process yields through rigorous control of production equipment and process variables. One.

In a Dec. 2, 2019 press release, BioMed X has announced the successful completion of its first joint research project in the fields of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) that it had undertaken with Boehringer Ingelheim. The project, which l.

Catalent and Ethicann Pharmaceuticals have announced a partnership aimed at developing a new combination pharmaceutical-grade cannabidiol (CBD) and tetrahydricannabinol (THC) product to treat multiple sclerosis (MS) spasticity using Catalent s orally disintegrating tablet technology (Zydis).

A drug discovery company based in the United Kingdom, Lunac Therapeutics, has been awarded funding worth 3.14 million (US$4.11 million) under Innovate UK s Biomedical Catalyst program. The funding, which has been provided to Lunac Therapeutics along with the Medicines Discovery Catapult a.

Mentions

Hints:

Mentions

Chemicals - Agricultural

Chemicals - Industrial

Business Issues

Companies - Public

Companies - Venture Funded

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints: